The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ERIC, VLTA and AUPH Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CABA, ERIC and ABBV Pharmaceutical Investing
DEADLINE ALERT for ABBV, MYPS, SDIG, LICY: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VLTA, IBM and AUPH Pharmaceutical Investing
Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Pharmaceutical Investing
LAWSUITS FILED AGAINST FB, ABBV and MYPS - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer Steerable Delivery Sheath for the Company's Amulet Device Pharmaceutical Investing
Allergan, an AbbVie Company, to Present New Data from its Leading Portfolio of Eye Care Treatments at the 2022 Association for Research in Vision and Ophthalmology Annual Meeting Pharmaceutical Investing
Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions Pharmaceutical Investing
New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes Pharmaceutical Investing
